Watch webinar

Enter your details below to access the audio and video recording of this event, and to receive updates about future virtual events.


If you’re already subscribed to IN-PART, please enter your details and you’ll be taken to the recordings.

In the light of the pandemic and the ever-increasing digitisation of collaboration, companies driven by innovation and R&D are focused on staying ahead of the curve and their competitors. A key aspect of this is the pursuit of the next academic breakthrough or expert to strengthen their pipeline.

In a new live online event series, ‘Models of Open Innovation’, industry leaders from innovative companies were interviewed by IN-PART to establish new best practices for academic partnering and scouting. 

  • 00:00 – Introduction to IN-PART
  • 02:59 – Introduction to Healx
  • 08:33 – How Healx build their clinical pipelines
  • 09:56 – What academic opportunities are Healx looking for?
  • 11:00 – Interactive poll and discussion: Which sector/role do you work in?
  • 12:14 – Interactive poll and discussion: Which approaches generate the most success?
  • 20:56 – Interactive poll and discussion: What are the biggest challenges when partnering?
  • 25:23 – Live Q&A
  • 44:24 – Closing remarks

Some of the topics covered include:

  • How Healx define technical and scientific R&D/innovation priorities
  • How the company finds solutions from academia
  • What their evaluation process looks like
  • How Healx stay ahead of the curve when sourcing innovation


Who is this webinar for?

  • R&D managers and heads
  • Open/external innovation teams
  • Business development & licensing heads
  • Search and evaluation scouts


Hosted by…


Alex Stockham, Head of Communications & Marketing at IN-PART

After studying chemistry (BSc) and science communication (MSc) at the University of Sheffield, Alex joined IN-PART in 2015 with the company founders working out of university incubators in Sheffield and London. Alex is responsible for IN-PART’s communications, marketing, and partnerships. 


Healx Speakers…


Bruce Bloom, Chief Collaboration Officer

Bruce founded Cures Within Reach, a US-based global non-profit driving “new” treatments to patients through repurposing research. He continues to be a strong global proponent of drug, device and nutraceutical repurposing as a critical component of therapy development in his current role.


Clara Tang, Alliance Strategy Manager

Clara has a Neuroscience PhD from the University of Cambridge and possesses expertise in life sciences market analysis, commercial strategy and project management. Clara has volunteering experience as a Medical Research Strategy Advisor and is a licensed Mental Health First Aider. 


What is IN-PART?


To help get breakthroughs out of the lab and onto the market, we’ve simplified the initial connection between academia and industry with two solutions:


Connect, a digital partnering platform for university-industry collaboration.

250+ universities and research institutes around the world currently showcase their research and innovation on IN-PART to find new collaboration partners with R&D teams in 6,000+ companies.

Discover, a bespoke scouting service for open innovation.

For a specific research requirement or challenge, Discover enables R&D teams to identify opportunities for commercialisation or to solicit proposals for new research across an extended network of academic teams and departments in 1,400+ institutes.

In conversation with Healx

Image credit: National Cancer Institute / Unsplash License


Working in a company?

Gain a competitive advantage by identifying cutting-edge innovation and expertise from universities and institutes worldwide.

Get started

Are you an academic?

Advance research, generate impact and secure funding by partnering with industry teams around the world.

Get started

Part of a university?

Engage with industry teams from all sectors looking for a wide range of opportunities from early-stage to late-stage research, technologies, spin-outs and expertise for consultancy.

Request a demo